Form 4: Fonar Corp Completes Acquisition Merger

Fonar Corporation has completed its merger, resulting in the cancellation of common stock for $19.00 per share.

Summary

• Fonar Corporation completed a merger agreement originally dated December 23, 2025.
• The company merged with FONAR Acquisition Sub, Inc., becoming a wholly owned subsidiary of FONAR, LLC.
• All outstanding common stock was cancelled and converted into the right to receive $19.00 per share.
• Reporting person Luciano B. Bonanni is no longer subject to Section 16 reporting requirements due to the completion of the merger.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing confirming the completion of a previously announced corporate transaction.

Positives

• Shareholders received a cash consideration of $19.00 per share upon the completion of the merger.

Negatives

• The company is no longer a publicly traded entity as it has become a wholly owned subsidiary.

Risks

• The company has ceased to be an independent public issuer, eliminating future public market participation for investors.

Future Outlook

The company has been acquired and is now a wholly owned subsidiary; therefore, no further public guidance or forward-looking statements are applicable.

Industry Context

StockSavvy.ai notes that this transaction represents a definitive exit from public markets for Fonar Corporation, consistent with broader trends of private equity or strategic consolidation in the medical technology sector.

Comparison to Industry Standards

• The $19.00 per share cash-out represents the final valuation for public shareholders, effectively ending the company's status as a listed entity.

Stakeholder Impact

• Shareholders have had their equity converted to cash at $19.00 per share.
• The company is now a private entity under the control of FONAR, LLC.

Next Steps

• Delisting of common stock from public exchanges.

Key Dates

Keywords

Fonar, FONR, Merger, Acquisition, Take-private, SEC Form 4